Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 11

Issues

The sudden death of the combined first trimester aneuploidy screening, a single centre experience in Belgium

Jan Van Elslande / Nathalie Brison / Joris R. Vermeesch / Koenraad Devriendt / Kris Van Den Bogaert / Eric Legius / Marc Van Ranst
  • Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, University of Leuven, Leuven, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Pieter Vermeersch / Jaak Billen
  • Corresponding author
  • Clinical Department of Laboratory Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium, Phone: 003216347015, Fax: 003216347931
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-05-21 | DOI: https://doi.org/10.1515/cclm-2019-0231

References

  • 1.

    Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, et al. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening. Cochrane Database of Systematic Reviews 2017; 3: Article No.: CD012600. DOI: 10.1002/14651858.CD012600.Web of ScienceGoogle Scholar

  • 2.

    Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol 2017;49:714–20.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 3.

    Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obs Gynecol 2017;50:302–14.CrossrefGoogle Scholar

  • 4.

    Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman OA, Madan J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016;6:e010002.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 5.

    Badeau M, Lindsay C, Blais J, Nshimyumukiza L, Takwoingi Y, Langlois S, et al. Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. Cochrane Database of Systematic Reviews 2017;11: Article No.: CD011767. DOI: 10.1002/14651858.CD011767.pub2.Web of ScienceGoogle Scholar

  • 6.

    Neyt M, Hulstaert F, Gyselaers W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open 2014;4:e005922.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 7.

    Bayindir B, Dehaspe L, Brison N, Brady P, Ardui S, Kammoun M, et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet 2015;23:1286–93.Web of SciencePubMedCrossrefGoogle Scholar

  • 8.

    Brison N, Neofytou M, Dehaspe L, Bayindir B, Van Den Bogaert K, Dardour L, et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat Diagn 2018;38:258–66.Web of ScienceCrossrefPubMedGoogle Scholar

  • 9.

    Brison N, Van Den Bogaert K, Dehaspe L, van den Oever JME, Janssens K, Blaumeiser B, et al. Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies. Genet Med 2017;19:306–13.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 10.

    Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, De Jonge ET, Ombelet WU, et al. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization. Ultrasound Obstet Gynecol 2004;24:511–5.PubMedCrossrefGoogle Scholar

About the article

aPieter Vermeersch and Jaak Billen contributed equally to this work.


Received: 2019-02-27

Accepted: 2019-04-04

Published Online: 2019-05-21

Published in Print: 2019-10-25


Funding Source: KU Leuven

Award identifier / Grant number: C1/018

Funding Source: Horizon 2020 WIDENLIFE

Award identifier / Grant number: 692065

The study was funded by the KU Leuven (C1/018) and the Horizon 2020 WIDENLIFE: 692065 to J.R.V.


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Employment or leadership: PV is a senior clinical investigator of the Research Foundation-Flanders (FWO).

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 11, Pages e294–e297, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0231.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Liesbeth Lenaerts, Kristel Van Calsteren, Huiwen Che, Joris Robert Vermeesch, and Frédéric Amant
Prenatal Diagnosis, 2019

Comments (0)

Please log in or register to comment.
Log in